Trials / Recruiting
RecruitingNCT04724603
Phage Safety Retrospective Cohort Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (estimated)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whether these adverse effects are related to surgery, antibiotic treatment or bacteriophages.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | patients having had avderse event after phagotherapy for bone or joint or implant infection | to determine the accountability of adverse effects in having had avderse event after phagotherapy for bone or joint or implant infection |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2022-08-01
- Completion
- 2026-09-01
- First posted
- 2021-01-26
- Last updated
- 2023-04-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04724603. Inclusion in this directory is not an endorsement.